Been figuring the best way to write my thanks to you all for your comments on Part 1, so, tryin’ this.
Whilst I have been reading your comments I have also been reading ‘The paper in the packet’ for each of the drugs that I originally referred to. It does seem as though each of these three DOAC's side effects can make a contribution to my experiences to one degree or another.
Although it’s dangerous to generalise I sense a bit of a pattern with your 16 comments. 1st, is - those of us who have been on these DOAC’s since they became available in the market place ( about 3 years ago ) AND 2ND - those of us who started on the forerunners of these DOAC’s ( maybe 10, 15 or longer years ago ) then switched since they have been on the market ( the last say 3 years).
It seems that those who are new to AF and have gone straight onto Atorvastatin, Edoxaban and Nebivolol have little or no problem. Those of us who kicked off with Simvastatin, Warfarin and Bisoprolol, THEN switched in recent years could be candidates for problems.
So when I talk to my Surgery Pharmacist on Tuesday I shall ask to return to Warfarin and dump Edoxaban, I will ask to return to Simvastatin and dump Atorvastatin and finally stay with Bisoprolol but start at 1.25mg and if necessary build up the size of doses. ( When I was originally put on Bisop my dose was 5mg ). When I was put on Nebivolol it was at 3.75mg.
The thing is I went from Jan 2010 to August 2023 on Warfarin, Bisoprolol and Simvastatin without any trouble. From Sept 2023 to March 2024 I was progressively switched to the DOAC's ( as we know them ) and then lurched into all the problems I've discussed 😱😱😱
Thanks everyone, hope you might have learned something from my post as I have from your replies.
John